AU3459593A - Humanised antibody against hepatitis - Google Patents
Humanised antibody against hepatitisInfo
- Publication number
- AU3459593A AU3459593A AU34595/93A AU3459593A AU3459593A AU 3459593 A AU3459593 A AU 3459593A AU 34595/93 A AU34595/93 A AU 34595/93A AU 3459593 A AU3459593 A AU 3459593A AU 3459593 A AU3459593 A AU 3459593A
- Authority
- AU
- Australia
- Prior art keywords
- antibody against
- against hepatitis
- humanised antibody
- humanised
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929202796A GB9202796D0 (en) | 1992-02-11 | 1992-02-11 | Antiviral antibody |
GB9202796 | 1992-02-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3459593A true AU3459593A (en) | 1993-09-03 |
Family
ID=10710132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU34595/93A Abandoned AU3459593A (en) | 1992-02-11 | 1993-02-09 | Humanised antibody against hepatitis |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU3459593A (en) |
GB (1) | GB9202796D0 (en) |
WO (1) | WO1993016192A1 (en) |
ZA (1) | ZA93928B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US20060257890A1 (en) * | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
IL118626A0 (en) | 1996-06-11 | 1996-10-16 | Xtl Biopharmaceuticals Limited | Anti HBV antibody |
US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
GB9712512D0 (en) | 1997-06-16 | 1997-08-20 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
DE19980730D2 (en) * | 1998-04-28 | 2001-05-10 | Wolfgang Bergter | Radioimmunopharmaceuticals for the treatment of hepatitis C |
KR100345463B1 (en) * | 1998-11-19 | 2003-01-08 | 주)녹십자 | Preparation of humanized antibody on surface antigen pre-s1 of hepatitis b virus |
ES2346659T3 (en) * | 1999-09-27 | 2010-10-19 | Genentech, Inc. | MANUFACTURING PROCEDURES FOR RECOMBINANT PROTEINS USING APOPTOSIS INHIBITORS. |
KR100484054B1 (en) * | 2000-10-02 | 2005-04-20 | 한국생명공학연구원 | A humanized antibody to surface antigen S of hepatitis B virus and a preparing method thereof |
CN1395617A (en) * | 2000-10-02 | 2003-02-05 | 韩国生命工学研究院 | A humanized antibody to surface antigen S of hepatitis B virus and preparing method thereof |
US6958213B2 (en) | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
US20020086292A1 (en) | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
GB2528401A (en) | 2011-05-06 | 2016-01-20 | Nvip Pty Ltd | Anti-nerve growth factor antibodies and methods of preparing and using the same |
KR101783929B1 (en) | 2011-05-06 | 2017-10-11 | 넥스베트 오스트레일리아 피티와이 리미티드 | Anti-nerve growth factor antibodies and methods of preparing and using the same |
GB201114858D0 (en) | 2011-08-29 | 2011-10-12 | Nvip Pty Ltd | Anti-nerve growth factor antibodies and methods of using the same |
-
1992
- 1992-02-11 GB GB929202796A patent/GB9202796D0/en active Pending
-
1993
- 1993-02-09 WO PCT/GB1993/000267 patent/WO1993016192A1/en active Application Filing
- 1993-02-09 AU AU34595/93A patent/AU3459593A/en not_active Abandoned
- 1993-02-10 ZA ZA93928A patent/ZA93928B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA93928B (en) | 1994-08-10 |
WO1993016192A1 (en) | 1993-08-19 |
GB9202796D0 (en) | 1992-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4618193A (en) | Humanized antibodies | |
AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
AU3459593A (en) | Humanised antibody against hepatitis | |
PL309249A1 (en) | Humanised antibodies against l-selectin | |
AU4025193A (en) | Humanized C-erbB-2 specific antibodies | |
PL314908A1 (en) | Humanised antibodies and their application | |
AU5283893A (en) | Recombinant humanized anti-cytomegalovirus antibodies | |
AU3811495A (en) | Antibodies | |
AU7041996A (en) | Antibody specific for beta1->6N- acetylglucosamininyltransferase | |
AU6080794A (en) | Antibodies directed against binding-associated epitopes | |
AU4841593A (en) | Improved handtruck | |
AU5732694A (en) | Humanized antibodies reactive with cd18 | |
GB9412166D0 (en) | Retargetting antibodies | |
AU7766391A (en) | Thrombus-specific antibody derivatives | |
AU2645297A (en) | Hepatitis b monoclonal antibodies | |
EP0580859A4 (en) | Anti-eda monoclonal antibody | |
AU2097592A (en) | Fibrinogen-specific monoclonal antibody and uses thereof | |
AU3330689A (en) | Monoclonal antibodies | |
AU4450389A (en) | Anti-fucosylcermiade monoclonal antibody | |
AU6725190A (en) | Anti-platelet monoclonal antibody | |
AU4195793A (en) | Bispecific antibody | |
AU6059194A (en) | Monoclonal antibodies to bovine cytokines | |
AU8547291A (en) | Monoclonal antibodies against tenascin | |
AU3107389A (en) | Chimeric antibodies directed against metal chelates | |
AU5425194A (en) | Detection of anti-hpa antibodies |